|
 |
| home > pmps > summer 2004 > validation and management of the project development process |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Legal and regulatory issues continue to increase in stringency; for example, recent moves by the US Food and Drug Administration (FDA) against the threat of bioterrorism and the introduction of 21 CFR Part 11 compliance. Coupled with these considerations are increasing commercial pressures affecting pricing, product life cycles and the costly quest for new molecules. All of these factors have caused many pharmaceutical companies to rethink manufacturing policy, as well as their approach to project management and standardisation.
Therefore, pharmaceutical companies have never been under more demanding conditions than now, with the constrictions of legislation and rising investment requirements applying further pressures. As a result, most companies are having to consider very carefully how they develop and deliver new drug products.
A pre-eminent specialist in pharmaceutical plant design, Professor W J Lhoest (1) identified in a paper published in 2000 that rationalisation had to occur in the industry. He stated that: "rationalisation means a combination of efforts in multiple directions: simplification of manufacturing systems, a reduction of the production cycle time, a decrease in the number of different raw materials and also the number of commercial presentations, rationalisation of packaging formats, optimisation of batch sizes, a drastic simplification of the paperwork, elimination of staging, automation of material handling, and the clever but reasonable use of computers.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
7th Annual Pharma Packaging and Labelling conference
17 September - 18 October 2008, Barcelona
7th Annual Pharma Packaging and Labelling conference will bring
together experts from leading pharma manufacturers to present case study driven
presentations on critical industry-wide issues.
Attending this event will give you an opportunity to discuss with fellow
packaging and labelling professionals and share your views on these important
matters.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
